Pierre-Yves Dumas

Pierre-Yves Dumas

UNVERIFIED PROFILE

Are you Pierre-Yves Dumas?   Register this Author

Register author
Pierre-Yves Dumas

Pierre-Yves Dumas

Publications by authors named "Pierre-Yves Dumas"

Are you Pierre-Yves Dumas?   Register this Author

22Publications

806Reads

31Profile Views

Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?

Int J Mol Sci 2019 Jul 12;20(14). Epub 2019 Jul 12.

Institut National de la Santé et de la Recherche Médicale, U1035 Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20143429DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679203PMC
July 2019

Natural killer cells and other innate lymphoid cells in cancer.

Nat Rev Immunol 2018 11;18(11):671-688

Innate Pharma Research Labs, Innate Pharma, Marseille, France.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41577-018-0061-z
Publisher Site
http://dx.doi.org/10.1038/s41577-018-0061-zDOI Listing
November 2018

Author Correction: Natural killer cells and other innate lymphoid cells in cancer.

Nat Rev Immunol 2018 Nov;18(11):726

Innate Pharma Research Labs, Innate Pharma, Marseille, France.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41577-018-0077-4
Publisher Site
http://dx.doi.org/10.1038/s41577-018-0077-4DOI Listing
November 2018

Improved Survival by Adding Lomustine to Conventional Chemotherapy for Elderly Patients With AML Without Unfavorable Cytogenetics: Results of the LAM-SA 2007 FILO Trial.

J Clin Oncol 2018 Sep 27:JCO2018787366. Epub 2018 Sep 27.

Arnaud Pigneux and Pierre-Yves Dumas, Bordeaux University Hospital, Bordeaux University, INSERM 1035; Louis-Rachid Salmi, Ariane Mineur, and Julien Asselineau, Bordeaux University Hospital, Bordeaux; Marie C. Béné, and Jacques Delaunay, Nantes University Hospital, Nantes; Caroline Bonmati, Nancy University Hospital, Nancy; Romain Guièze, Clermont-Ferrand University Hospital, Clermont Ferrand; Isabelle Luquet, Eric Delabesse, and Christian Récher, Toulouse University Hospital, Toulouse; Pascale Cornillet-Lefebvre, Reims University Hospital, Reims; Jean-Christophe Ianotto, Brest University Hospital, Brest; Mario Ojeda-Uribe, Mulhouse Regional Hospital, Mulhouse; Mathilde Hunault and Norbert Ifrah, Angers University Hospital and INSERM U 892/CNRS 6299, Angers; Anne Banos, Cote Basque General Hospital, Bayonne; Luc Matthieu Fornecker, Strasbourg University Hospital, Strasbourg; Marc Bernard, Rennes University Hospital, Rennes; Eric Jourdan, Nîmes University Hospital, Nîmes; Norbert Vey, Institut Paoli Calmettes, Marseilles; Hacene Zerazhi, Avignon General Hospital, Avignon; Yosr Hishri, Montpellier University Hospital, Montpellier; Roselyne Delepine, Tours University Hospital, Tours; and Jean-Yves Cahn, Grenoble University Hospital, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.7366DOI Listing
September 2018

BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib.

Ann Hematol 2017 Feb 20;96(2):335-336. Epub 2016 Oct 20.

CHU de Bordeaux, Hematology Department, Pessac, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2855-zDOI Listing
February 2017

Rituximab for the treatment of adult relapsed/refractory CD20 positive B-ALL patients: a pilot series.

Leuk Res 2012 Mar 14;36(3):311-5. Epub 2011 Dec 14.

Service d'Hématologie Clinique, CHU Hôtel Dieu, Université de Nantes, Centre d'Investigation Clinique en Cancerologie (CI2C) and INSERM U892, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.11.010DOI Listing
March 2012